Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. VitaCig, Inc.
WARNING LETTER
•VitaCig, Inc.•December 7, 2021

VitaCig, Inc. – FDA Warning Letter, Dec 7, 2021

Record Details

The FDA issued a Warning Letter to VitaCig Group on December 1, 2021, following a September 2021 review of their website, vitaciggroup.com. The FDA determined that VitaCig's "VitaCig products," including "Classic edition" and "S-edition" inhalers, and "Excalibur" rechargeable inhaler capsules, are unapproved new drugs.

The products are deemed drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), due to claims on their website indicating intent for disease treatment/prevention or affecting body structure/function. Examples of such claims include benefits for heart health, immunity, weight loss, cancer prevention, improved digestion, erectile dysfunction, cognitive enhancement, and treatment for anxiety/depression.

These products are considered "new drugs" under section 201(p) of the FD&C Act, 21 U.S.C. 321(p), as they are not generally recognized as safe and effective for their claimed uses. Introducing or delivering these unapproved new drugs into interstate commerce violates sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d). The

Company
VitaCig, Inc.
Inspection date
December 7, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Carolyn E. Becker
View Company Profile

ID · 0c0e2c2c-d79c-45e5-981a-06fb1120a4a9

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore VitaCig, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.